This meta-analysis of four randomized trials confirmed that beta-blockers after MI in patients with preserved ejection fraction do not improve cardiovascular outcomes. The consolidated evidence definitively supports discontinuation in this population.
This meta-analysis of 4 randomized clinical trials assesses whether β-blockers are associated with improved cardiovascular outcomes after myocardial infarction in patients with preserved left ventricular ejection fraction.
